Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENNYWISE Feasibility
2018-000774-30Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in myocardial infarction (MI) comparing Prolonged enoxaparin with Standard-of-care therapy (2 arms). Primary endpoint: Recruitment rate over the study period. Started Jun 2018; status: completed.
02
Drugs
enoxaparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2018-000774-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000774-30.